IE 11 is not supported. For an optimal experience visit our site on another browser.

Myriad Genetics to Report Fiscal 2011 First Quarter Financial Results on November 2

SALT LAKE CITY, Oct. 12, 2010 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it will release its fiscal 2011 first quarter financial results at the close of market on Tuesday, November 2, 2010.
/ Source: GlobeNewswire

SALT LAKE CITY, Oct. 12, 2010 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it will release its fiscal 2011 first quarter financial results at the close of market on Tuesday, November 2, 2010.

The Company will host a conference call on Tuesday, November 2, at 4:30 p.m. Eastern to review the financial results. Participating on the call will be: Peter D. Meldrum, President and Chief Executive Officer; Jim Evans, Chief Financial Officer; and Mark C. Capone, President of Myriad Genetic Laboratories, Inc.

To participate on the call, callers may dial (800) 753-4387 or (212) 231-2906 approximately 10-15 minutes before the start of the call. All callers will be asked to reference reservation number 21484421.

The conference call also will be available to interested parties through a live audio Internet broadcast at . 

A replay of the call will be available beginning two hours after the end of the call until seven days following the call and may be accessed by dialing (800) 633-8284 or (402) 977-9140, and entering the reservation number 21484421.

Myriad Genetics, Inc. is a leading molecular diagnostic company focused on developing and marketing novel predictive medicine, personalized medicine and prognostic medicine products. Myriad's news and other information are available on the Company's Web site at . MYGN-F

The Myriad Genetics, Inc. logo is available at

CONTACT: Myriad Genetics, Inc. Suzanne Barton, Director, Investor Relations (801) 584-1138 sbarton@myriad.com